Send any comments to our Customer care

| E-mail this Web page | Print this Web page

Migrin™

Important note: Migrin™ has been discontinued by its manufacturer. We recommend using Extress™ as a substitute.

Migrin™

Product description

Migrin™ provides nutritional support during migraines. Migraine-like headaches are believed to be the result of certain neural cells misfiring within the brain, causing serotonin levels to fall, blood flow to increase and head pressure to mount. The ingredients in Migrin™ aid in naturally reducing the pain, inflammation and discomfort of migraine-like headaches.

Key ingredients in this dietary supplement are DL-Phenylalanine, White Willow Bark Feverfew and some amino acids.

Product description
Migrin suppresses headaches, migraines, and inflammation while providing nutritional support to the brain with DL-Phenylalanine, White Willow Bark (Feverfew) and some amino acids. A bottle of Migrin™

Product description
  • 60 capsules per bottle
Product description

Migrin™ provides support during migraines and is known to:

  • help calm and stabilize blood vessels to allow proper blood flow
  • help promote smooth neurotransmission and diminish the reactive misfirings of neurons
  • help maintain appropriate serotonin levels within the brain
  • help promote naturally occurring "pain-relievers" (endorphins and enkephalins)
Product description

Take 2 capsules in the morning and in the evening, or as directed by your health professional.

During migraine attacks, take 4 to 6 capsules every 3 hours, or as directed by your health professional.

Product description

Migrin™ supplement facts:

Serving size: 1 capsule (775 mg)

Servings per container: 60


Amount per capsule %DV
Niacinamide (Vitamin B3) 30 mg 150%
Vitamin B6 (Pyridoxine HCl) 5 mg 250%
Proprietary blend: 740 mg *
DL-Phenylalanine (DLPA)    
White Willow Bark    
Tanacetum Parthenium (Feverfew)    
Iris versicolor    
L-Asparagine    
L-Glutamic acid    
L-Glutamine    
Choline bitartrate    
L-Taurine    
DL-Methionine    
L-Alanine    
L-Glycine    
Micro-nutritionals:    
Calcarea aceticum    
Cocculus indicus    
Chelidonium majus    
Ignatia amara    
Iris versicolor    
Natrum muriaticum    
Silica    
*Daily Value not established.


Product description
  • Pregnant or nursing women must consult a physician before using this product.
  • Consult a physician if you are taking prescriptive medications while using Migrin™.
  • If conditions persist or worsen consult a health professional.
  • Keep out of reach of children.
Product description
  • Shelf life is up to 2 years for an unopened product
  • Shelf life is 6 months for an opened product
Product description

Studies show that electrical stimulation within the mid-brain, in the area of the dorsal raphe neurons (specific neural cells which have the highest concentration of serotonin receptors and subsequently alter cerebral blood flow), can result in the cascading activity of falling serotonin levels, which increases blood flow and results in migraine-like headaches. Thus, headaches may be diminished naturally by inhibiting the firing of these neurons.

Migrin™ is a dietary supplement with the specific nutrients of key amino acids and supporting phytomedicinals that aid the body in regulating serotonin utilization and shutting down inhibitory systems while not increasing blood flow, all of which act to provide relief from pain. It is a safe and non-addictive formulation which will not interfere with other medications but act to enhance their respective potency, as well as acting as a safe non-addicting mild mood elevator. When taken regularly, this dietary formula acts as a nutritional "fortifier" providing the body with the means to help itself against further attacks of severe headache, as well as to help reduce the overall frequency.

The body is capable of shunting trillions upon trillions of signals and information through its neural pathways each minute of the day, day after day, year after year, seemingly without stopping. In order to do this, specific nutrients are required in order to allow the smooth conveyance of neural information from one cell to another. Often, in cases of excessive mental nervousness, uncontrolled agitation and other neurological dysfunction such as seizure and epilepsy, the specific nutritive requirements within the body cannot be met. When this occurs, the ordinarily smooth-running neural system finds itself proverbially "up the creek without a paddle." Often, neural messages become confused, some neural pathways become "short circuited," and there may be a great deal of misfiring or over-firing of neurons causing memory failure, uncontrolled agitation, nervous and muscle spasm or different forms of seizures, including those which are epileptic in nature, small and large alike.

Historically, an understanding of migraines has evolved from that of a "vascular" model to one which more correctly is a type of "spreading cortical" phenomenon of 3 phases.

It was widely held for many years that the headache phase of migrainous attacks was caused by extracranial vasodilatation and that neurologic symptoms were produced by intracranial vasoconstriction, the "vascular" hypothesis of migraine. A barrage of publications followed in support of this hypothesis so that differing observations were sadly ignored. However, observations made over the past decade have finally rendered untenable the "vascular" hypothesis and lend support to what is known as a "spreading depression" model.

(Please note that this is not a state of psychological depression, but rather "depressed" or diminished cortical activity.)

Despite the fact that this model has some 50 years of history, it was vigorously resisted because it could not possibly be incorporated into the "vascular" model of migraine, which had previously been tenaciously grasped by the medical community.

Now, the "spreading depression" model has found more acceptance, and is described as a slowly moving (2 to 3 mm/min) potassium-liberating "depression" of cortical activity, preceded by a wavefront of increased metabolic activity that can be produced by a variety of experimental stimuli, including hypoxia, mechanical trauma, and the topical application of potassium.

The pathogenesis of migraine as it is currently understood can be partitioned into three phases:

  1. Brain (stem) generation.

  2. "Vasomotor activation" wherein arteries both within and outside the brain may contract or dilate.

  3. Activation of cells of the medullary trigeminal nucleus caudalis (the brain's head and face pain-processing mechanism) and the subsequent release of vasoactive neuropeptides at vascular terminations of the trigeminal nerve.

This last phase provides a reasonable mechanism for the soft-tissue swelling and tenderness of blood vessels that attend migraine attacks. It seems clear that activation of any of the phases is sufficient for headache production, and that perhaps any one phase may appear to dominate in a particular migrainous syndrome.

Electrical stimulation within the mid-brain near the area of the dorsal raphe neurons, can result in migraine like headaches. There are projections from the dorsal raphe that terminate on cerebral arteries and alter cerebral blood flow. There are also major projections from the dorsal raphe to important visual processing way stations, including the lateral geniculate body, superior colliculus, retina, and visual cortex.

Now, it appears that platelet levels of serotonin fall consistently at the onset of headache and that migrainous episodes may be triggered by drugs that release serotonin. The highest concentration of serotonin receptors exist within the mid-brain dorsal raphe area. When overstimulation of these neurons occur, an overabundance of serotonin is realeased, over relaxing neurons and causing them to misfire which causes blood flow to increase and enlarge arteries, leading to common migraine symptoms such as head and eye pain.

The dorsal raphe cells stop firing during deep sleep, and sleep is known to ameliorate migraine; the anti-migraine drugs also stop the firing of the dorsal raphe cells through a direct or indirect agonist effect. The shutdown of an inhibitory system might be expected to enhance or stabilize neurotransmission, and there is evidence that this indeed occurs. Migraine may represent, therefore, a hereditary perturbation of serotonergic neurotransmission. Such perturbation may underlie many types of head pain; ordinary periodic headaches may be the "noise" of the normally functioning system.

Specifically, Migrin™ complements the body nutritively by ensuring an abundant supply of biochemical precursors, such as DLPA (DL-Phenylalanine), which acts, via PEA mechanisms (Phenylethylamine) to regulate serotonin production and utilization, thus inhibiting the mechanism of migraine modeled after the "spreading depression."

L-Glutamic acid, and its uncharged amide, L-Glutamine, act as inhibitory neurotransmitters, being taken up by the all important glial cells. The glial cells (or glia) are the supporting, non-neuronal cells of the central nervous system (CNS). They are as important as the neurons, which could not function without them. They wrap around and enclose the axons, dendrites, synapses and blood vessels. They probably control the composition of the interstitial medium. There are about ten times more glial cells than neurons in the CNS.

After Glutamic acid uptake via the glial cells, Glutamine is quickly converted to Glutamic acid, and then diffused into the neurons, resupplying glutamine deficiencies. Glutamic acid as an excitatory neurotransmitter, balancing the possibility of inhibitory overload (shutting down the inhibitory systems of GABA) so that the smooth muscles of vascular groups do not become too relaxed, and thus add to the severity of migraine and cluster headaches. L-Asparagine is a neutral amino acid necessary for secretory calcium-binding protein activity; the presence of Ca2+ ions are mandatory and regulatory within the central nervous system.

Migrin™ has been developed especially for those requiring nutritional support when under a physician's care and experiencing migraine headaches and related problems. Migraine and frontal headaches are often violent, severe and incapacitating, with often accompanying reoccurring shooting pains through the temples, and with accompanying constipation, nausea, fainting, vomiting and irritability, blurring of sight, hallucinations, obscuration of sight, neuralgia and twitching of limbs, pains running from the neck into the head made worse by sudden movement, increased tactile and photo-sensitivity.


Key ingredients of Migrin™:


DL-Phenylalanine:
DL-Phenylalanine (DLPA) acts via PEA mechanisms to regulate serotonin production and utilization, thus inhibiting the "spreading depression" model of migraines; nutritionally inhibits the production of enzymes which defeat naturally occurring "pain-relievers" (endorphins and enkephalins), aiding the reduction of pain and inflammation.
L-Glutamic acid:
L-Glutamic acid acts both as an inhibitory and excitatory neurotransmitter, resupplying deficiencies in neurons and supporting glial cells, shutting down the inhibitory systems of GABA or Gamma-aminobutyric acid, so that the smooth muscles in veins and arteries don't overdialate.
L-Glutamine:
Amino acids that act both as inhibitory and excitatory neurotransmitters, resupplying deficiencies in neurons and supporting glial cells, shutting down the inhibitory systems of GABA or Gamma-aminobutyric acid, so that the smooth muscles in veins and arteries don't overdialate.
White Willow Bark:
White Willow Bark is thought to inhibit the neural transfer of pain signals. White Willow Bark contains the natural pharmaceutically active compound salicin, or salicylic acid, the chemical forerunner of acetylsalicylic acid (modern aspirin), known to complement the body's ability to relieve discomfort but without the possible complications caused by aspirin.
Tanacetum Parthenium :
Tanacetum Parthenium (Feverfew) is used since ancient times for severe headaches and migraines, recent research has revealed its anti-inflammatory properties, allowing a stabilization of cerebral blood vessels by counteracting those substances that permit excessive blood flow which enlarges the arteries.
L-Taurine:
L-Taurine is an amino acid with natural calming properties, acting as major inhibitory neurotransmitters of the brain and found useful in soothing the uncontrolled agitation and reactive misfiring of neurons.
L-Glycine:
L-Glycine is an amino acid with natural calming properties, acting as major inhibitory neurotransmitters of the brain and found useful in soothing the uncontrolled agitation and reactive misfiring of neurons.
Iris Versicolor:
Iris Versicolor is known to work upon the nervous system, and is used for migraine and cluster headaches as yet another anti-dialator.
L-Alanine:
L-Alanine helps buffer the body's natural inhibitory neuro-transmitters which are thought be useful in disorders involving excessive or sporadic neuro-transmission.
Free form amino acids:
Free form amino acids, specifically targeted micro-nutritionals and other ingredients provide electromagnetic instructions to further support the body's abilities to address inflammation and pain.
Product description
Migrin™ $24.95
 
Place your order
 

Product description

For any suspected or known illness or dysfunction, always consult your physician for medical diagnosis and treatment first.

Statements contained in this Web site have not been evaluated by the Food and Drug Administration (FDA).

No products mentioned in this Web site are intended to diagnose, treat, cure, or prevent any disease.

Product description

Home | Contact us | Site map | FAQ | Customer care | Help